MedDataX Logo

Social Media Use in Sickle Cell Patients

NCT ID: NCT05182216

Last Updated: 2023-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Surveys of patients to identify primary social media sources for health news.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sickle Cell Disease: A Retrospective Chart Review

NCT01441375

Sickle Cell Anemia
COMPLETED

Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease

NCT01369160

Sickle Cell Disease
COMPLETED

Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center

NCT00005327

Anemia, Sickle Cell Blood Disease Cerebrovascular Disorders +1 more
COMPLETED

SCD Fit Homebase Program

NCT05228756

Cardiovascular Diseases Sickle Cell Disease Exercise
WITHDRAWN NA

Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])

NCT00529061

Anemia, Sickle Cell
TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Survey, Family Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* sickle cell disease diagnosis

Exclusion Criteria

* negative sickle cell disease diagnosis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sonja Smith

Program Manager

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

300007766

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I
NCT03069430 COMPLETED
Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research
NCT03709303 COMPLETED
Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
NCT06071377 RECRUITING
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
NCT05170412 RECRUITING
Improving Self-Management in Adolescents With Sickle Cell Disease
NCT02851615 COMPLETED NA
Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)
NCT00528203 TERMINATED
Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
NCT04416178 RECRUITING
Effectiveness of Laying-on-of-hands for Sickle Cell Disease
NCT01518218 COMPLETED PHASE2
Sickle Cell, Pain and Mediterranean Diet
NCT06886477 RECRUITING NA
Obesity in Pediatric Sickle Cell Disease: A New Phenomenon
NCT04676113 COMPLETED
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease
NCT03376893 RECRUITING
Role of Placenta Growth Factor in Sickle Acute Chest Syndrome
NCT00448370 COMPLETED
Telemedicine for Children With Sickle Cell Disease
NCT05087303 RECRUITING NA
Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I
NCT01256281 TERMINATED PHASE1
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease
NCT04091737 TERMINATED PHASE1
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 RECRUITING
Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
NCT01054768 COMPLETED PHASE2
Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center
NCT00005326 COMPLETED
Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging
NCT03478917 COMPLETED
The Dallas Hereditary Spherocytosis Cohort Study
NCT01141621 TERMINATED
Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease
NCT02200510 COMPLETED NA
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 COMPLETED
Acute Kidney Injury in Patients With Sickle Cell Disease
NCT03105271 COMPLETED
Sickle Cell Hemoglobinopathies and Bone Health
NCT02306993 ACTIVE_NOT_RECRUITING
Assessing Function in Pediatric Patients With Sickle Cell Disease
NCT00590148 COMPLETED